Eleving Group S.A. approves Share Buy-Back Programme

On 29 June 2026, the Management Board of Eleving Group (the "Company", ISIN: LU2818110020, ticker: ELEVR), implementing the authority granted by the Annual General Meeting of shareholders held on 27 May 2026, resolved to adopt a share buy-back programme (the "Programme") for the Company's ordinary shares. Programme Parameters

Securities	Ordinary shares (ISIN: LU2818110020, ticker: ELEVR)
Trading venues	Nasdaq Riga regulated market (Baltic Main List); Frankfurt Stock Exchange regulated market (Prime Standard)
Maximum number of shares	5,855,440 shares (~5% of issued share capital)
Maximum aggregate consideration	EUR 5,000,000 (excluding acquisition costs and commissions)
Maximum purchase price	The higher of: (i) the price of the last independent trade; or (ii) the highest current independent bid on Nasdaq Riga at the time of purchase, as required by Article 3(2) of Commission Delegated Regulation (EU) 2016/1052
Daily volume limit	Up to 25% of average daily trading volume on each venue, calculated over the 20 trading days preceding each transaction
Programme start date	1 July 2026
Programme end date	30 June 2028
Purpose	Cancellation of shares (capital reduction); and/or coverage of employee share option and equity incentive plans

Trading Methods Acquisitions under the Programme will be carried out on-exchange on Nasdaq Riga and the Frankfurt Stock Exchange. The Company may also conduct off-market (OTC) block transactions on a case-by-case basis, subject to compliance with the general market abuse rules under MAR; OTC acquisitions will not be conducted during any closed period or any period in which undisclosed inside information is held.
The Company may appoint an independent investment services provider (the "Independent Broker") to execute on-exchange acquisitions on its behalf in accordance with Article 4(2)(b) of Commission Delegated Regulation (EU) 2016/1052, enabling acquisitions to continue during closed periods under MAR Article 19(11), subject to the conditions of that provision being met. The Company will not use derivative financial instruments in connection with the Programme. Regulatory Compliance The Programme is conducted in compliance with Regulation (EU) No 596/2014 on market abuse (MAR) as amended by Regulation (EU) 2024/2809 (EU Listing Act, in force 4 December 2024), and Commission Delegated Regulation (EU) 2016/1052, including the safe harbour conditions set out in Article 5 of MAR.
The Programme has been authorised pursuant to Article 430-15 of the Luxembourg Law of 10 August 1915 on commercial companies, as amended, by the AGM Resolution of 27 May 2026. Additional Information The full Programme Description, prepared pursuant to Article 2 of Commission Delegated Regulation (EU) 2016/1052, is available on the Company's investor relations website at www.eleving.com.
For further information:
Elīna Dobulāne
Group’s Chief Corporate Affairs Officer, Eleving Group
elina.dobulane@eleving.com | +371 25959447